Funabashi, Japan

Seiya Terai

This inventor holds 1 USPTO granted patent and 3 published patent applications and 1 EPO patent. Top assignee: Nissan Chemical Industries Limited. Active years: 2018.

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2018

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Seiya Terai: Innovator in Aniline Derivatives

Introduction

Seiya Terai is a notable inventor based in Funabashi, Japan. He has made significant contributions to the field of organic electroluminescent elements through his innovative work on aniline derivatives. His research has implications for enhancing the longevity and performance of electronic devices.

Latest Patents

Seiya Terai holds 1 patent for his invention titled "Aniline derivatives and uses thereof." This patent focuses on aniline derivatives that exhibit excellent solubility in organic solvents. These compounds are particularly valuable for creating organic electroluminescent elements, as they improve the longevity of thin films used in hole injection layers.

Career Highlights

Throughout his career, Seiya Terai has worked with prominent companies, including Nissan Chemical Industries Limited and Nissan Chemical Corporation. His experience in these organizations has allowed him to apply his innovative ideas in practical settings, contributing to advancements in chemical applications.

Collaborations

Seiya Terai has collaborated with talented individuals such as Naoki Nakaie and Taichi Nakazawa. These partnerships have fostered a creative environment that has led to the development of groundbreaking technologies.

Conclusion

Seiya Terai's work on aniline derivatives showcases his innovative spirit and dedication to advancing technology in the field of organic electronics. His contributions are paving the way for future developments in this exciting area.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…